We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$324B
$67.5M 0.63%
1,245,536
-11,818
-0.9% -$612K
HD icon
27
Home Depot
HD
$332B
$67.3M 0.62%
850,840
+136,564
+19% +$10.9M
VEA icon
28
Vanguard FTSE Developed Markets ETF
VEA
$226B
$67M 0.62%
1,623,747
+206,933
+15% +$8.48M
EMR icon
29
Emerson Electric
EMR
$82.9B
$66.3M 0.62%
992,125
-5,026
-0.5% -$331K
ACN icon
30
Accenture
ACN
$89.9B
$64.6M 0.6%
810,482
+155,965
+24% +$12.8M
AXP icon
31
American Express
AXP
$223B
$63.8M 0.59%
708,134
-5,745
-0.8% -$513K
LLY icon
32
Eli Lilly
LLY
$1.07T
$60.5M 0.56%
1,027,924
+554,735
+117% +$31M
HON icon
33
Honeywell
HON
$77.1B
$59.5M 0.55%
714,017
+34,739
+5% +$2.88M
ABT icon
34
Abbott
ABT
$180B
$59.1M 0.55%
1,534,999
-82,231
-5% -$3.17M
CL icon
35
Colgate-Palmolive
CL
$72.6B
$57.9M 0.54%
891,845
-96,965
-10% -$6.11M
T icon
36
AT&T
T
$165B
$57.2M 0.53%
2,160,425
+124,674
+6% +$3.13M
USB icon
37
US Bancorp
USB
$99.6B
$55.6M 0.52%
1,297,090
+8,023
+0.6% +$330K
VIG icon
38
Vanguard Dividend Appreciation ETF
VIG
$111B
$53.6M 0.5%
711,859
+16,285
+2% +$1.2M
BEN icon
39
Franklin Resources
BEN
$16.9B
$53.5M 0.5%
986,977
-15,338
-2% -$826K
BAX icon
40
Baxter International
BAX
$11.6B
$53.4M 0.5%
1,336,441
-12,935
-1% -$484K
ABBV icon
41
AbbVie
ABBV
$458B
$52.1M 0.48%
1,014,062
-102,201
-9% -$5.17M
AGN
42
DELISTED
Allergan Inc
AGN
$51M 0.47%
411,375
-3,588
-0.9% -$437K
COP icon
43
ConocoPhillips
COP
$147B
$47.5M 0.44%
675,166
-15,989
-2% -$1.07M
MCD icon
44
McDonald's
MCD
$188B
$45M 0.42%
459,416
+10,360
+2% +$991K
YUM icon
45
Yum! Brands
YUM
$41B
$43.9M 0.41%
809,374
-13,569
-2% -$715K
OMC icon
46
Omnicom Group
OMC
$22.7B
$41.5M 0.39%
572,254
-4,541
-0.8% -$334K
NEE icon
47
NextEra Energy
NEE
$187B
$41.3M 0.38%
1,725,656
-26,084
-1% -$591K
GOOG icon
48
Alphabet (Google) Class C
GOOG
$3.9T
$41M 0.38%
1,477,919
-80,019
-5% -$2.33M
GLW icon
49
Corning
GLW
$126B
$41M 0.38%
1,969,300
+34,573
+2% +$650K
KO icon
50
Coca-Cola
KO
$354B
$40.6M 0.38%
1,051,185
-233,782
-18% -$9.03M
1
2
3 4 5

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.